Nordea 1 - Nordic Equity Fund BC GBP

Category Nordic Equity
star-filledstar-filledstar-filled
This fund can be held in an Investment ISA, SIPP and Investment Account
Last buy/sell price

£22.0076

arrow-down£-0.022 (-0.10%)

Fund Code

NOEQA

B9MT3G4

LU0841548497

Prices updated as at 29 Apr 2024
|
Prices in GBP
Investment objective
To provide shareholders with investment growth in the long term. The fund mainly invests in equities of Nordic companies. Specifically, the fund invests at least 75% of total assets in equities and equity-related securities issued by companies that are domiciled, or conduct the majority of their business, in the Nordic region. In actively managing the fund’s portfolio, the management team selects companies that appear to offer superior growth prospects and investment characteristics.
Important documents: Please ensure that you have read the Key Information Document/Technical Guide
, Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.

Annual charges

Product charges
1.25
0.06
No
-
0.00
0.00
Minimum investment25.00

Documents

Document nameDate postedDownload
Annual Reports 31 Mar 2024pdf
Interim Short Report 31 Mar 2024pdf
Key Information Document / Technical Guide 15 Feb 2024pdf
Annual Short Report 31 Dec 2022pdf
Please note that service charges will also apply. Read more about our fees.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.